The review highlights how disrupting the cell cycle, a process often hijacked by cancer cells for unchecked growth offers a promising strategy for cancer therapy. It focuses on drugs that precisely target key cell cycle regulators, several of which are already in clinical use. By showcasing the latest breakthroughs and outlining future research directions, the article provides a comprehensive look at how targeting cell cycle dysregulation is shaping the future of cancer care.

Researchers have unveiled the transformative potential of micropattern arrays—engineered microstructures—to probe and guide cellular biomechanics. These arrays not only help decipher how cells sense physical cues but also steer tissue regeneration and stem cell fate, paving the way for breakthroughs in tissue regeneration, organ-on-a-chip systems, and disease modeling.

A team of researchers at NYU Abu Dhabi has uncovered a key mechanism that helps shape how our brains are wired, and what can happen when that process is disrupted.

United Rare Earths has licensed two innovative technologies from Oak Ridge National Laboratory aimed at reducing dependence on critical rare earth elements. These technologies support the creation of high-performance magnets engineered to use significantly less rare earth content.

Dr. Meng Wang, assistant professor of civil and environmental engineering at the University of Pittsburgh Swanson School of Engineering, has received a prestigious National Science Foundation (NSF) Faculty Early Career Development (CAREER) Award of $550,000 to develop a nanostructure cocktail of enzymes that will more efficiently break down toxic materials without producing dangerous intermediates. His project, “Advancing Biodegradation Through Protein Nanocompartment-Based Cargo Encapsulation for Organic Contaminant Removal,” seeks to dramatically improve biodegradation while advancing biomanufacturing.